Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Total Current Liabilities (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Total Current Liabilities for 11 consecutive years, with $95.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities fell 14.32% year-over-year to $95.1 million, compared with a TTM value of $95.1 million through Dec 2025, down 14.32%, and an annual FY2025 reading of $95.1 million, down 14.32% over the prior year.
  • Total Current Liabilities was $95.1 million for Q4 2025 at Wave Life Sciences, up from $85.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $186.4 million in Q4 2023 and bottomed at $31.6 million in Q3 2021.
  • Average Total Current Liabilities over 5 years is $99.3 million, with a median of $87.4 million recorded in 2025.
  • The sharpest move saw Total Current Liabilities plummeted 71.15% in 2021, then surged 160.68% in 2023.
  • Year by year, Total Current Liabilities stood at $64.2 million in 2021, then grew by 11.4% to $71.5 million in 2022, then skyrocketed by 160.68% to $186.4 million in 2023, then tumbled by 40.49% to $111.0 million in 2024, then decreased by 14.32% to $95.1 million in 2025.
  • Business Quant data shows Total Current Liabilities for WVE at $95.1 million in Q4 2025, $85.9 million in Q3 2025, and $87.4 million in Q2 2025.